BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1947794)

  • 1. Formation of covalent C3b-tetanus toxin complexes: a tool for the in vitro study of antigen presentation.
    Villiers MB; Villiers CL; Wright JF; Maison CM; Colomb MG
    Scand J Immunol; 1991 Nov; 34(5):585-95. PubMed ID: 1947794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3b covalently associated to tetanus toxin modulates TT processing and presentation by U937 cells.
    Rey-Millet CA; Villiers CL; Gabert FM; Chesne S; Colomb MG
    Mol Immunol; 1994 Dec; 31(17):1321-7. PubMed ID: 7997244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production.
    Serra VA; Cretin F; Pépin E; Gabert FM; Marche PN
    Eur J Immunol; 1997 Oct; 27(10):2673-9. PubMed ID: 9368625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells.
    Villiers MB; Villiers CL; Jacquier-Sarlin MR; Gabert FM; Journet AM; Colomb MG
    Immunology; 1996 Nov; 89(3):348-55. PubMed ID: 8958046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
    Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3b complexation diversifies naturally processed T cell epitopes.
    Cretin FC; Serra VA; Villiers MB; Laharie AM; Marche PN; Gabert FM
    Mol Immunol; 2007 Apr; 44(11):2893-9. PubMed ID: 17320958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide linkage between C3b and tetanus toxin on tetanus toxin-specific EBV-transformed B cells.
    Jacquier MR; Gabert FM; Villiers CL; Colomb MG
    J Immunol; 1993 May; 150(10):4253-60. PubMed ID: 8387092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3.
    Muñoz E; Vidarte L; Casado MT; Pastor C; Vivanco F
    Int Immunol; 1998 Feb; 10(2):97-106. PubMed ID: 9580208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associated complement C3b. Towards an understanding of its intracellular modifications.
    Rey-Millet CA; Chesne S; Colomb MG
    Mol Immunol; 1993 Jul; 30(10):855-64. PubMed ID: 8341280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E; Sim RB
    Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells.
    Santoro L; Drouet C; Reboul A; Mach JP; Colomb MG
    Eur J Immunol; 1994 Jul; 24(7):1620-6. PubMed ID: 8026522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of the antibody response by C3b complexed to antigen through an ester link.
    Villiers MB; Villiers CL; Laharie AM; Marche PN
    J Immunol; 1999 Mar; 162(6):3647-52. PubMed ID: 10092826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I).
    Kinoshita T; Nussenzweig V
    J Immunol Methods; 1984 Jul; 71(2):247-57. PubMed ID: 6376638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of the C3b-inactivator on the cell-bound C3b.
    Law SK; Fearon DT; Levine RP
    J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.